Given that the proportion of CD8 TE cells was significantly increased in CML patients, we speculate that CD8 TE cells may be an important factor causing the immune difference between CML patients and healthy people. This evidence concerns the gene CD8A and chronic myelogenous leukemia, BCR-ABL1 positive.